JP7363189B2 - Film coating composition, solid preparation, and method for producing solid preparation - Google Patents
Film coating composition, solid preparation, and method for producing solid preparation Download PDFInfo
- Publication number
- JP7363189B2 JP7363189B2 JP2019151722A JP2019151722A JP7363189B2 JP 7363189 B2 JP7363189 B2 JP 7363189B2 JP 2019151722 A JP2019151722 A JP 2019151722A JP 2019151722 A JP2019151722 A JP 2019151722A JP 7363189 B2 JP7363189 B2 JP 7363189B2
- Authority
- JP
- Japan
- Prior art keywords
- coating composition
- coating
- film coating
- solid preparation
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 37
- 239000007888 film coating Substances 0.000 title claims description 32
- 238000009501 film coating Methods 0.000 title claims description 32
- 239000007787 solid Substances 0.000 title claims description 20
- 238000002360 preparation method Methods 0.000 title claims description 17
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 238000000576 coating method Methods 0.000 claims description 60
- 239000011248 coating agent Substances 0.000 claims description 56
- 229920005989 resin Polymers 0.000 claims description 48
- 239000011347 resin Substances 0.000 claims description 48
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 47
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 47
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 22
- 239000001087 glyceryl triacetate Substances 0.000 claims description 20
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 20
- 229960002622 triacetin Drugs 0.000 claims description 20
- 238000007127 saponification reaction Methods 0.000 claims description 18
- 229920001567 vinyl ester resin Polymers 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 6
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims description 4
- 235000000346 sugar Nutrition 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims 1
- 239000003826 tablet Substances 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 238000001035 drying Methods 0.000 description 15
- 238000004140 cleaning Methods 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- -1 talc (for example Chemical class 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000007423 decrease Effects 0.000 description 10
- 239000000178 monomer Substances 0.000 description 10
- 238000006116 polymerization reaction Methods 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000007941 film coated tablet Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 239000000454 talc Substances 0.000 description 7
- 229910052623 talc Inorganic materials 0.000 description 7
- 235000012222 talc Nutrition 0.000 description 7
- 239000000654 additive Substances 0.000 description 6
- 239000008199 coating composition Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- 150000002484 inorganic compounds Chemical class 0.000 description 4
- 229910010272 inorganic material Inorganic materials 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 229920001290 polyvinyl ester Polymers 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000007940 sugar coated tablet Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000002981 blocking agent Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000002662 enteric coated tablet Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 229960003511 macrogol Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000000379 polymerizing effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 239000008119 colloidal silica Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- ZQMIGQNCOMNODD-UHFFFAOYSA-N diacetyl peroxide Chemical compound CC(=O)OOC(C)=O ZQMIGQNCOMNODD-UHFFFAOYSA-N 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- UIZVMOZAXAMASY-UHFFFAOYSA-N hex-5-en-1-ol Chemical compound OCCCCC=C UIZVMOZAXAMASY-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000003746 surface roughness Effects 0.000 description 2
- 238000009492 tablet coating Methods 0.000 description 2
- 239000002700 tablet coating Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ORTVZLZNOYNASJ-UPHRSURJSA-N (z)-but-2-ene-1,4-diol Chemical compound OC\C=C/CO ORTVZLZNOYNASJ-UPHRSURJSA-N 0.000 description 1
- VAYTZRYEBVHVLE-UHFFFAOYSA-N 1,3-dioxol-2-one Chemical compound O=C1OC=CO1 VAYTZRYEBVHVLE-UHFFFAOYSA-N 0.000 description 1
- BCITXCOYSHAADW-UHFFFAOYSA-N 1-[2-(4-oxoheptoxymethyl)prop-2-enoxy]heptan-4-one Chemical compound C(CCC(=O)CCC)OCC(COCCCC(=O)CCC)=C BCITXCOYSHAADW-UHFFFAOYSA-N 0.000 description 1
- CRSBERNSMYQZNG-UHFFFAOYSA-N 1-dodecene Chemical compound CCCCCCCCCCC=C CRSBERNSMYQZNG-UHFFFAOYSA-N 0.000 description 1
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- FKAKGSJLTBVQOP-UHFFFAOYSA-N 2-(acetyloxymethyl)prop-2-enyl acetate Chemical compound CC(=O)OCC(=C)COC(C)=O FKAKGSJLTBVQOP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- XCOWGEAIBVSRDR-UHFFFAOYSA-N 2-methylprop-2-enyl propanoate Chemical compound CCC(=O)OCC(C)=C XCOWGEAIBVSRDR-UHFFFAOYSA-N 0.000 description 1
- IGDCJKDZZUALAO-UHFFFAOYSA-N 2-prop-2-enoxypropane-1,3-diol Chemical group OCC(CO)OCC=C IGDCJKDZZUALAO-UHFFFAOYSA-N 0.000 description 1
- ZSPTYLOMNJNZNG-UHFFFAOYSA-N 3-Buten-1-ol Chemical compound OCCC=C ZSPTYLOMNJNZNG-UHFFFAOYSA-N 0.000 description 1
- BJWMSGRKJIOCNR-UHFFFAOYSA-N 4-ethenyl-1,3-dioxolan-2-one Chemical compound C=CC1COC(=O)O1 BJWMSGRKJIOCNR-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- DFINTYMPPWPMIF-UHFFFAOYSA-N CC(=O)OC(OC(C)=O)=CCO Chemical compound CC(=O)OC(OC(C)=O)=CCO DFINTYMPPWPMIF-UHFFFAOYSA-N 0.000 description 1
- PYWZZOUJUFYWJT-UHFFFAOYSA-N CC(=O)OCC=C(C)OC(C)=O Chemical compound CC(=O)OCC=C(C)OC(C)=O PYWZZOUJUFYWJT-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004348 Glyceryl diacetate Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- HETCEOQFVDFGSY-UHFFFAOYSA-N Isopropenyl acetate Chemical group CC(=C)OC(C)=O HETCEOQFVDFGSY-UHFFFAOYSA-N 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- VZUAUHWZIKOMFC-ONEGZZNKSA-N [(e)-4-acetyloxybut-2-enyl] acetate Chemical compound CC(=O)OC\C=C\COC(C)=O VZUAUHWZIKOMFC-ONEGZZNKSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- RZJRJXONCZWCBN-UHFFFAOYSA-N alpha-octadecene Natural products CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003006 anti-agglomeration agent Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- ITMIAZBRRZANGB-UHFFFAOYSA-N but-3-ene-1,2-diol Chemical compound OCC(O)C=C ITMIAZBRRZANGB-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 229950008138 carmellose Drugs 0.000 description 1
- 239000012461 cellulose resin Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000012674 dispersion polymerization Methods 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- YCUBDDIKWLELPD-UHFFFAOYSA-N ethenyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC=C YCUBDDIKWLELPD-UHFFFAOYSA-N 0.000 description 1
- WNMORWGTPVWAIB-UHFFFAOYSA-N ethenyl 2-methylpropanoate Chemical compound CC(C)C(=O)OC=C WNMORWGTPVWAIB-UHFFFAOYSA-N 0.000 description 1
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 description 1
- CMDXMIHZUJPRHG-UHFFFAOYSA-N ethenyl decanoate Chemical compound CCCCCCCCCC(=O)OC=C CMDXMIHZUJPRHG-UHFFFAOYSA-N 0.000 description 1
- GLVVKKSPKXTQRB-UHFFFAOYSA-N ethenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC=C GLVVKKSPKXTQRB-UHFFFAOYSA-N 0.000 description 1
- GFJVXXWOPWLRNU-UHFFFAOYSA-N ethenyl formate Chemical compound C=COC=O GFJVXXWOPWLRNU-UHFFFAOYSA-N 0.000 description 1
- AFSIMBWBBOJPJG-UHFFFAOYSA-N ethenyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC=C AFSIMBWBBOJPJG-UHFFFAOYSA-N 0.000 description 1
- BLZSRIYYOIZLJL-UHFFFAOYSA-N ethenyl pentanoate Chemical compound CCCCC(=O)OC=C BLZSRIYYOIZLJL-UHFFFAOYSA-N 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000019443 glyceryl diacetate Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- IFNMFFFINNZGER-UHFFFAOYSA-N hexa-1,5-dien-3-one Chemical compound C=CCC(=O)C=C IFNMFFFINNZGER-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 1
- 229940012189 methyl orange Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- OMNKZBIFPJNNIO-UHFFFAOYSA-N n-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical compound CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 description 1
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadec-1-ene Chemical compound CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000006191 orally-disintegrating tablet Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- LQAVWYMTUMSFBE-UHFFFAOYSA-N pent-4-en-1-ol Chemical compound OCCCC=C LQAVWYMTUMSFBE-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- UIIIBRHUICCMAI-UHFFFAOYSA-N prop-2-ene-1-sulfonic acid Chemical compound OS(=O)(=O)CC=C UIIIBRHUICCMAI-UHFFFAOYSA-N 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- KOZCZZVUFDCZGG-UHFFFAOYSA-N vinyl benzoate Chemical compound C=COC(=O)C1=CC=CC=C1 KOZCZZVUFDCZGG-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical compound OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Description
本発明は、フィルムコーティング組成物並びにこれを用いた固形製剤及びその製造方法に関する。 The present invention relates to a film coating composition, a solid preparation using the same, and a method for producing the same.
錠剤は、薬の成分を圧縮するなどして、一定量の薬を簡単に服用することができるように一定の形に作られる。ひと口に「錠剤」と言っても、その飲み方や使い方、作られ方によって、いろいろなタイプがある。腸溶錠や徐放錠、糖衣錠・フィルムコーティング錠、口腔内崩壊錠、チュアブル錠、付着錠など、目的や効果によって選択される。 Tablets are made by compressing drug ingredients into a specific shape so that a fixed amount of the drug can be easily taken. Even though they are called ``tablets,'' there are various types depending on how they are taken, how they are used, and how they are made. Enteric-coated tablets, sustained-release tablets, sugar-coated tablets, film-coated tablets, orally disintegrating tablets, chewable tablets, adhesive tablets, etc. are selected depending on the purpose and effect.
フィルムコーティング錠や糖衣錠は、経口固形製剤における、薬物の不快な味に対するマスキング、酸素の遮断、防湿又は製品としての美観の向上等の目的で広く用いられている。 Film-coated tablets and sugar-coated tablets are widely used in oral solid preparations for purposes such as masking unpleasant taste of drugs, blocking oxygen, moisture proofing, and improving the aesthetic appearance of the product.
糖衣錠・フィルムコーティング錠は、錠剤の周りを糖やフィルムで覆うことで、薬の成分本来の苦みや臭みを隠し、飲みやすくした錠剤である。また、コーティングすることで薬を光や湿気から守って、安定性が増すなどの効果が出る場合もある。 Sugar-coated tablets and film-coated tablets are tablets that are made easier to swallow by covering the tablet with sugar or film to hide the bitterness and odor of the medicine's ingredients. Coatings can also have effects such as protecting drugs from light and moisture and increasing their stability.
近年、錠剤コーティング組成物として、ガスバリア性に優れたポリビニルアルコール系樹脂(以下、PVA系樹脂という。)を含有する組成物が検討されている。PVA系樹脂をコーティング組成物として用いる場合、PVA系樹脂単体では、コーティングした錠剤同士がくっつく、スティッキングが生じやすく、ポリエチレングリコール(粘着防止剤)を含有させること(例えば、特許文献1)やヒドロキシプロピルメチルセルロース(HPMC)を含有させること(例えば、特許文献2)、またタルクなどの無機化合物を含有させること(例えば、特許文献3)が提案されていた。 In recent years, compositions containing polyvinyl alcohol resins (hereinafter referred to as PVA resins) with excellent gas barrier properties have been studied as tablet coating compositions. When using PVA-based resin as a coating composition, PVA-based resin alone tends to cause sticking, in which coated tablets stick to each other. It has been proposed to include methyl cellulose (HPMC) (for example, Patent Document 2) and to contain an inorganic compound such as talc (for example, Patent Document 3).
しかしながら、特許文献1のようにポリエチレングリコールを含有させると錠剤同士が接着する(くっつく)スティッキング現象は解消されるが、錠剤の吸湿性が高くなることが問題となっている。また、特許文献2のようにスティッキング防止のためにHPMCなどのセルロース系樹脂を併用することも提案されているが、溶液粘度が高いため、コーティング液の固形分濃度を上げることができず、コーティング時間や乾燥時間が長く、また水蒸気バリア性が十分でないことが問題であった。さらに、特許文献3のようにスティッキング防止のためにタルクなどの無機化合物を含有することも提案されているが、無機化合物の含有量を多くしなければならず、被膜の柔軟性が低下することが問題であった。 However, when polyethylene glycol is included as in Patent Document 1, the sticking phenomenon in which tablets adhere to each other (sticking together) is eliminated, but the problem is that the hygroscopicity of the tablets increases. Furthermore, as in Patent Document 2, it has been proposed to use a cellulose resin such as HPMC in combination to prevent sticking, but due to the high solution viscosity, it is not possible to increase the solid content concentration of the coating liquid, and the coating Problems include long drying times and insufficient water vapor barrier properties. Furthermore, as in Patent Document 3, it has been proposed to contain an inorganic compound such as talc to prevent sticking, but the content of the inorganic compound must be increased, which reduces the flexibility of the film. was the problem.
本発明は、スティッキングを解消し、吸湿性が低いフィルムコーティング組成物を提供することを目的とする。 The present invention aims to provide a film coating composition that eliminates sticking and has low hygroscopicity.
本発明者らは、上記課題を解決するために鋭意検討を重ねた結果、PVA系樹脂と特定の粘着防止剤を併用することで上記目的が達成されることを見出し、本発明を完成した。 As a result of intensive studies to solve the above problems, the present inventors have found that the above objects can be achieved by using a PVA-based resin and a specific anti-blocking agent in combination, and have completed the present invention.
かかる効果は、ポリビニルアルコール系樹脂と特定の粘着防止剤の併用によりスティッキングを防止し、連続層を形成できたことで得られたものであると推測される。 It is presumed that this effect was achieved by the combined use of a polyvinyl alcohol resin and a specific anti-blocking agent to prevent sticking and form a continuous layer.
本発明のフィルムコーティング組成物は、スティッキングが解消され、かつ錠剤の吸湿性が低いフィルムコーティング組成物を提供できる。 The film coating composition of the present invention can provide a film coating composition that eliminates sticking and provides tablets with low hygroscopicity.
以下、本発明の構成につき詳細に説明するが、これらは望ましい実施態様の一例をして示すものである。
本発明のフィルムコーティング組成物は、ポリビニルアルコール系樹脂(A)とトリアセチン(B)を含有するものである。
Hereinafter, the structure of the present invention will be explained in detail, but these are shown as examples of desirable embodiments.
The film coating composition of the present invention contains a polyvinyl alcohol resin (A) and triacetin (B).
まずは、PVA系樹脂(A)について説明する。
本発明で用いられるPVA系樹脂(A)は、ビニルエステル系モノマーを重合して得られるポリビニルエステル系重合体をケン化して得られる、ビニルアルコール構造単位を主体とする樹脂であり、ケン化度相当のビニルアルコール構造単位と、ケン化されずに残ったビニルエステル構造単位から構成される。
First, the PVA resin (A) will be explained.
The PVA resin (A) used in the present invention is a resin mainly composed of vinyl alcohol structural units, which is obtained by saponifying a polyvinyl ester polymer obtained by polymerizing vinyl ester monomers, and has a degree of saponification. It is composed of a corresponding vinyl alcohol structural unit and a vinyl ester structural unit that remains unsaponified.
PVA系樹脂(A)のケン化度は70~100モル%であり、好ましくは、75~98モル%、更に好ましくは80~95モル%、特に好ましくは85~93モル%である。PVA系樹脂(A)のケン化度が低すぎる、スティッキングが生じやすくなる傾向があり、高すぎると、溶液の安定性が低下する傾向がある。
なお、本発明において、PVA系樹脂(A)のケン化度は、JIS K 6726に準拠する方法で求められた値とする。
The degree of saponification of the PVA resin (A) is 70 to 100 mol%, preferably 75 to 98 mol%, more preferably 80 to 95 mol%, particularly preferably 85 to 93 mol%. If the saponification degree of the PVA-based resin (A) is too low, sticking tends to occur easily, and if it is too high, the stability of the solution tends to decrease.
In the present invention, the degree of saponification of the PVA resin (A) is a value determined by a method based on JIS K 6726.
また、本発明に使用されるPVA系樹脂(A)の平均重合度は、100~3300であり、150~1000が好ましく、200~600が特に好ましい。
PVA系樹脂の平均重合度が低すぎると、緻密なコーティング層ができにくい傾向があり、平均重合度が高すぎると、コーティングスピードが低下する傾向がある。
なお、本発明において、PVA系樹脂の平均重合度は、JIS K 6726に準拠する方法で求めた平均重合度を用いるものとする。
Furthermore, the average degree of polymerization of the PVA resin (A) used in the present invention is from 100 to 3,300, preferably from 150 to 1,000, and particularly preferably from 200 to 600.
If the average degree of polymerization of the PVA-based resin is too low, a dense coating layer tends to be difficult to form, and if the average degree of polymerization is too high, the coating speed tends to decrease.
In the present invention, the average degree of polymerization of the PVA-based resin is determined by a method based on JIS K 6726.
またPVA系樹脂は、2種以上を併用することも有効である。併用する際には、ケン化度や平均重合度の異なるPVA系樹脂を併用することができる。併用する場合においてのPVA系樹脂のケン度、平均重合度は、PVA系樹脂全体の平均値が上記の範囲内であることが好ましい。 It is also effective to use two or more types of PVA resins in combination. When used in combination, PVA resins having different degrees of saponification and average degrees of polymerization can be used together. When used in combination, it is preferable that the average value of the saponity and average degree of polymerization of the PVA-based resin as a whole falls within the above range.
本発明で使用されるPVA系樹脂の製造方法を説明する。
PVA系樹脂は、例えば、ビニルエステル系モノマーを重合して得られたポリビニルエステル系重合体をケン化することにより得られる。
かかるビニルエステル系モノマーとしては、例えば、ギ酸ビニル、酢酸ビニル、プロピオン酸ビニル、バレリン酸ビニル、酪酸ビニル、イソ酪酸ビニル、ピバリン酸ビニル、カプリン酸ビニル、ラウリン酸ビニル、ステアリン酸ビニル、安息香酸ビニル、バーサチック酸ビニル等が挙げられ、実用的に酢酸ビニルが好適である。
A method for producing the PVA resin used in the present invention will be explained.
The PVA resin can be obtained, for example, by saponifying a polyvinyl ester polymer obtained by polymerizing a vinyl ester monomer.
Examples of such vinyl ester monomers include vinyl formate, vinyl acetate, vinyl propionate, vinyl valerate, vinyl butyrate, vinyl isobutyrate, vinyl pivalate, vinyl caprate, vinyl laurate, vinyl stearate, and vinyl benzoate. , vinyl versatate, etc., and vinyl acetate is practically preferred.
また、本発明の効果を阻害しない程度に、上記ビニルエステル系モノマーと共重合性を有するモノマーを共重合させることもでき、このような共重合モノマーとしては、例えば、エチレンやプロピレン、イソブチレン、α-オクテン、α-ドデセン、α-オクタデセン等のオレフィン類、3-ブテン-1-オール、4-ペンテン-1-オール、5-ヘキセン-1-オール、3,4-ジヒドロキシ-1-ブテン等のヒドロキシ基含有α-オレフィン類及びそのアシル化物などの誘導体、アクリル酸、メタクリル酸、クロトン酸、マレイン酸、無水マレイン酸、イタコン酸、ウンデシレン酸等の不飽和酸類、その塩、モノエステル、あるいはジアルキルエステル、アクリロニトリル、メタアクリロニトリル等のニトリル類、ジアセトンアクリルアミド、アクリルアミド、メタクリルアミド等のアミド類、エチレンスルホン酸、アリルスルホン酸、メタアリルスルホン酸等のオレフィンスルホン酸類あるいはその塩、アルキルビニルエーテル類、ジメチルアリルビニルケトン、N-ビニルピロリドン、塩化ビニル、ビニルエチレンカーボネート、2,2-ジアルキル-4-ビニル-1,3-ジオキソラン、グリセリンモノアリルエーテル、等のビニル化合物、酢酸イソプロペニル、1-メトキシビニルアセテート等の置換酢酸ビニル類、塩化ビニリデン、1,4-ジアセトキシ-2-ブテン、1,4-ジヒドロキシ-2-ブテン、ビニレンカーボネート、1,3-ジアセトキシ-2-メチレンプロパン、1,3-ジプロピオニルオキシ-2-メチレンプロパン、1,3-ジブチロニルオキシ-2-メチレンプロパン等のヒドロキシメチルビニリデンジアセテート等が挙げられる。かかる共重合モノマーの含有量は、重合体全量を基準として、通常10モル%以下、好ましくは5モル%以下、特に好ましくは1モル%以下である。本発明においては、付着性の点で、ビニルアルコール構造単位と未ケン化部分のビニルエステル構造単位のみからなる未変性PVA系樹脂が好ましい。 In addition, monomers having copolymerizability with the above-mentioned vinyl ester monomers can be copolymerized to the extent that the effects of the present invention are not impaired. Examples of such copolymerizable monomers include ethylene, propylene, isobutylene, α -Olefins such as octene, α-dodecene, α-octadecene, 3-buten-1-ol, 4-penten-1-ol, 5-hexen-1-ol, 3,4-dihydroxy-1-butene, etc. Derivatives such as hydroxy group-containing α-olefins and their acylated products, unsaturated acids such as acrylic acid, methacrylic acid, crotonic acid, maleic acid, maleic anhydride, itaconic acid, and undecylenic acid, their salts, monoesters, or dialkyl Esters, nitriles such as acrylonitrile and methacrylonitrile, amides such as diacetone acrylamide, acrylamide and methacrylamide, olefin sulfonic acids or their salts such as ethylene sulfonic acid, allyl sulfonic acid and methalylsulfonic acid, alkyl vinyl ethers, dimethyl Vinyl compounds such as allyl vinyl ketone, N-vinylpyrrolidone, vinyl chloride, vinyl ethylene carbonate, 2,2-dialkyl-4-vinyl-1,3-dioxolane, glycerin monoallyl ether, isopropenyl acetate, 1-methoxyvinyl Substituted vinyl acetates such as acetate, vinylidene chloride, 1,4-diacetoxy-2-butene, 1,4-dihydroxy-2-butene, vinylene carbonate, 1,3-diacetoxy-2-methylenepropane, 1,3-diacetoxy-2-butene, Examples include hydroxymethylvinylidene diacetate such as propionyloxy-2-methylenepropane and 1,3-dibutyronyloxy-2-methylenepropane. The content of such a copolymerizable monomer is usually 10 mol% or less, preferably 5 mol% or less, particularly preferably 1 mol% or less, based on the total amount of the polymer. In the present invention, from the viewpoint of adhesion, unmodified PVA-based resins consisting only of vinyl alcohol structural units and unsaponified vinyl ester structural units are preferred.
上記ビニルエステル系モノマー及び共重合モノマーを重合するにあたっては特に制限はなく、塊状重合、溶液重合、懸濁重合、分散重合、又は乳化重合等の公知の方法を採用することができるが、通常は溶液重合が行われる。 There are no particular restrictions on polymerizing the above vinyl ester monomers and copolymerizable monomers, and known methods such as bulk polymerization, solution polymerization, suspension polymerization, dispersion polymerization, or emulsion polymerization can be employed, but usually Solution polymerization is carried out.
かかる重合で用いられる溶媒としては、通常、メタノール、エタノール、イソプロピルアルコール、n-プロパノール、ブタノール等の炭素数1~4の脂肪族アルコールやアセトン、メチルエチルケトン等のケトン類等が挙げられ、工業的にはメタノールが好適に使用される。
また、重合反応は、例えば、アゾビスイソブチロニトリル、過酸化アセチル、過酸化ベンゾイル、過酸化ラウロイルなどの公知のラジカル重合触媒や公知の各種低温活性触媒を用いて行われる。また、反応温度は35℃~沸点程度の範囲から選択される。
Solvents used in such polymerization usually include aliphatic alcohols having 1 to 4 carbon atoms such as methanol, ethanol, isopropyl alcohol, n-propanol, and butanol, and ketones such as acetone and methyl ethyl ketone. Methanol is preferably used.
Further, the polymerization reaction is carried out using a known radical polymerization catalyst such as azobisisobutyronitrile, acetyl peroxide, benzoyl peroxide, lauroyl peroxide, or various known low-temperature active catalysts. Further, the reaction temperature is selected from a range of about 35° C. to the boiling point.
得られたポリビニルエステル系重合体は、次いで連続式又はバッチ式にてケン化し、PVA系樹脂が得られる。かかるケン化にあたっては、アルカリケン化又は酸ケン化のいずれも採用できるが、工業的には重合体をアルコールに溶解してアルカリ触媒の存在下に行われる。アルコールとしては、例えば、メタノール、エタノール、ブタノール等が挙げられる。アルコール中の重合体の濃度は20~60質量%の範囲から選ばれる。また、必要に応じて、0.3~10質量%程度の水を加えてもよく、更には、酢酸メチル等の各種エステル類やベンゼン、ヘキサン、DMSO(ジメチルスルホキシド)等の各種溶剤類を添加してもよい。 The obtained polyvinyl ester polymer is then saponified in a continuous or batch manner to obtain a PVA resin. In such saponification, either alkali saponification or acid saponification can be employed, but industrially it is carried out by dissolving the polymer in alcohol and in the presence of an alkali catalyst. Examples of the alcohol include methanol, ethanol, butanol, and the like. The concentration of the polymer in the alcohol is selected from the range 20-60% by weight. Furthermore, if necessary, about 0.3 to 10% by mass of water may be added, and various esters such as methyl acetate and various solvents such as benzene, hexane, and DMSO (dimethyl sulfoxide) may be added. You may.
ケン化触媒としては、例えば、水酸化ナトリウム、水酸化カリウム、ナトリウムメチラート、ナトリウムエチラート、カリウムメチラート等のアルカリ金属の水酸化物やアルコラートの如きアルカリ触媒を具体的に挙げることができ、かかる触媒の使用量はモノマーに対して1~100ミリモル当量にすることが好ましい。 Specific examples of the saponification catalyst include alkali catalysts such as alkali metal hydroxides and alcoholates such as sodium hydroxide, potassium hydroxide, sodium methylate, sodium ethylate, and potassium methylate. The amount of such catalyst used is preferably 1 to 100 millimole equivalents based on the monomer.
ケン化後、PVA系樹脂を、洗浄液で洗浄してもよい。洗浄液としては、例えば、メタノール、エタノール、イソプロピルアルコール、ブタノール等のアルコール類が挙げられ、洗浄効率と乾燥効率の観点からメタノールが好ましい。 After saponification, the PVA-based resin may be washed with a washing liquid. Examples of the cleaning liquid include alcohols such as methanol, ethanol, isopropyl alcohol, butanol, and methanol is preferred from the viewpoint of cleaning efficiency and drying efficiency.
洗浄方法としては、連続式(回転円筒型、向流接触型、遠心分離ふりかけ洗浄など)でもよいが、通常はバッチ式が採用される。洗浄時の攪拌方式(装置)としては、スクリュー翼、リボンブレンダー、ニーダー等が挙げられる。浴比(洗浄液の質量/ポリビニルエステル系重合体粒子の質量)は、通常、1~30であり、特に2~20が好ましい。浴比が大きすぎると、大きな洗浄装置が必要となり、コスト増につながる傾向があり、浴比が小さすぎると、洗浄効果が低下し、洗浄回数を増加させる傾向がある。 The cleaning method may be a continuous type (rotating cylinder type, countercurrent contact type, centrifugal separation sprinkle cleaning, etc.), but a batch type is usually adopted. Examples of stirring methods (devices) during cleaning include screw blades, ribbon blenders, kneaders, and the like. The bath ratio (mass of cleaning liquid/mass of polyvinyl ester polymer particles) is usually 1 to 30, particularly preferably 2 to 20. If the bath ratio is too large, a large cleaning device will be required, which tends to increase costs, and if the bath ratio is too small, the cleaning effect will decrease and the number of cleanings will tend to increase.
洗浄時の温度は、通常、10~80℃であり、特に20~70℃が好ましい。温度が高すぎると、洗浄液の揮発量が多くなり、還流設備を必要とする傾向がある。温度が低すぎると、洗浄効率が低下する傾向がある。洗浄時間は、通常、5分~12時間であり、特に30分~4時間が好ましい。洗浄時間が長すぎると、生産効率が低下する傾向があり、洗浄時間が短すぎると、洗浄が不十分となる傾向がある。また、洗浄回数は、通常、1~10回であり、特に1~5回が好ましい。洗浄回数が多すぎると、生産性が低下し、コストがかかる傾向がある。 The temperature during washing is usually 10 to 80°C, particularly preferably 20 to 70°C. If the temperature is too high, the amount of volatilization of the cleaning liquid increases, which tends to require reflux equipment. If the temperature is too low, cleaning efficiency tends to decrease. The washing time is usually 5 minutes to 12 hours, particularly preferably 30 minutes to 4 hours. If the cleaning time is too long, production efficiency tends to decrease, and if the cleaning time is too short, cleaning tends to be insufficient. Further, the number of times of washing is usually 1 to 10 times, particularly preferably 1 to 5 times. Too many washings tend to reduce productivity and increase costs.
洗浄されたPVA系樹脂(A)を連続式又はバッチ式にて熱風などで乾燥または減圧乾燥し、本発明で用いられるPVA系樹脂を得る。乾燥温度は、通常、50~150℃であり、特に60~130℃、殊に70~110℃が好ましい。乾燥温度が高すぎると、PVA系樹脂が熱劣化する傾向があり、乾燥温度が低すぎると、乾燥に長時間を要する傾向がある。乾燥時間は、通常、1~48時間であり、特に2~36時間が好ましい。乾燥時間が長すぎると、PVA系樹脂が熱劣化する傾向があり、乾燥時間が短すぎると、乾燥が不十分となったり、高温乾燥を要したりする傾向がある。 The washed PVA resin (A) is dried continuously or batchwise with hot air or under reduced pressure to obtain the PVA resin used in the present invention. The drying temperature is usually 50 to 150°C, particularly preferably 60 to 130°C, particularly preferably 70 to 110°C. If the drying temperature is too high, the PVA resin tends to be thermally degraded, and if the drying temperature is too low, the drying tends to take a long time. The drying time is usually 1 to 48 hours, particularly preferably 2 to 36 hours. If the drying time is too long, the PVA resin tends to be thermally degraded, and if the drying time is too short, the drying tends to be insufficient or high temperature drying is required.
乾燥後のPVA系樹脂(A)中に含まれる溶媒の含有量は、通常、0~10質量%であり、特に0.01~5質量%、殊に0.1~1質量%とするのが好ましい。 The content of the solvent contained in the PVA resin (A) after drying is usually 0 to 10% by mass, particularly 0.01 to 5% by mass, particularly 0.1 to 1% by mass. is preferred.
なお、PVA系樹脂(A)には、ケン化時に用いるアルカリ触媒に由来する酢酸のアルカリ金属塩が含まれている。アルカリ金属塩の含有量は、PVA系樹脂粉体に対して通常0.001~2質量%、好ましくは0.005~1質量%であり、更に好ましくは0.01~0.1質量%である。
アルカリ金属塩の含有量の調整方法としては、例えば、ケン化で用いる時のアルカリ触媒の量を調節したり、エタノールやメタノールなどのアルコールでPVA系樹脂を洗浄したりする方法が挙げられる。
本発明で用いるアルカリ金属塩の定量法としては、PVA系樹脂粉体を水に溶かして、メチルオレンジを指示薬とし、塩酸にて中和滴定により求める。
Note that the PVA-based resin (A) contains an alkali metal salt of acetic acid derived from the alkali catalyst used during saponification. The content of the alkali metal salt is usually 0.001 to 2% by mass, preferably 0.005 to 1% by mass, and more preferably 0.01 to 0.1% by mass based on the PVA resin powder. be.
Examples of methods for adjusting the alkali metal salt content include adjusting the amount of an alkali catalyst used in saponification and washing the PVA resin with alcohol such as ethanol and methanol.
The alkali metal salt used in the present invention can be determined by dissolving PVA resin powder in water, using methyl orange as an indicator, and performing neutralization titration with hydrochloric acid.
次にトリアセチン(B)について説明する。
本発明で用いられるトリアセチン(B)は、医薬品または食品の添加剤として用いられるトリアセチンが挙げられる。
Next, triacetin (B) will be explained.
Examples of the triacetin (B) used in the present invention include triacetin used as an additive for pharmaceuticals or foods.
次に本発明のフィルムコーティング組成物について説明する。
本発明のフィルムコーティング組成物中におけるPVA系樹脂(A)とトリアセチン(B)の含有量(A+B)としては、30~98質量%、好ましくは40~70質量%、更に好ましくは40~65質量%である。
かかる含有量が多すぎる場合、コーティング液の固形分濃度が上げることができず、コーティング時間が長くなる傾向があり、少なすぎる場合は乾燥に時間がかかり効率が低下する傾向がある。
Next, the film coating composition of the present invention will be explained.
The content (A+B) of PVA resin (A) and triacetin (B) in the film coating composition of the present invention is 30 to 98% by mass, preferably 40 to 70% by mass, more preferably 40 to 65% by mass. %.
If the content is too high, the solid content concentration of the coating liquid cannot be increased and the coating time tends to be longer; if the content is too low, drying takes a long time and efficiency tends to decrease.
またフィルムコーティング組成物中におけるPVA系樹脂(A)とトリアセチン(B)の含有量としては、PVA系樹脂(A)100重量部に対してトリアセチン(B)は18~40重量部であり、好ましくは19~38重量部、さらに好ましくは20~35重量部である。PVA系樹脂(A)の比率が多いと粘着性の改善が完全ではなくコーティング速度を上げることができず、一方で、トリアセチン(B)の比率が多いと吸湿性が高くなる傾向がある。 In addition, the content of PVA resin (A) and triacetin (B) in the film coating composition is preferably 18 to 40 parts by weight for 100 parts by weight of PVA resin (A). is 19 to 38 parts by weight, more preferably 20 to 35 parts by weight. If the ratio of PVA-based resin (A) is high, the adhesion will not be completely improved and the coating speed cannot be increased, while if the ratio of triacetin (B) is high, hygroscopicity tends to increase.
本発明のフィルムコーティング組成物は、溶媒に溶解し、コーティング液として、錠剤や顆粒、粒子等をコーティングするものである。
かかる溶媒としては、水、メタノール、エタノール、i-プロパノール、n-プロパノール、ブタノールなどが挙げられ、安全性の面から、好ましくは水である。
The film coating composition of the present invention is dissolved in a solvent and used as a coating liquid to coat tablets, granules, particles, etc.
Examples of such a solvent include water, methanol, ethanol, i-propanol, n-propanol, butanol, and water is preferred from the viewpoint of safety.
かかるコーティング液における、PVA系樹脂(A)とトリアセチン(B)を溶媒である水に溶解した溶液の23℃での粘度は、通常3~1000mPa・s、好ましくは25~700mPa・s、特に好ましくは30~300mPa・s、更に好ましくは35~250mPa・sである。
かかるコーティング液の粘度が高すぎると、コーティング液の流動性が低下し、コーティングしにくくなる傾向があり、逆に低すぎると、乾燥に時間がかかり効率が低下する傾向がある。
In such a coating liquid, the viscosity at 23° C. of a solution in which PVA resin (A) and triacetin (B) are dissolved in water as a solvent is usually 3 to 1000 mPa·s, preferably 25 to 700 mPa·s, particularly preferably is 30 to 300 mPa·s, more preferably 35 to 250 mPa·s.
If the viscosity of such a coating liquid is too high, the fluidity of the coating liquid tends to decrease, making coating difficult; on the other hand, if the viscosity is too low, drying takes a long time and efficiency tends to decrease.
またコーティング液中のPVA系樹脂(A)の濃度は、通常3~50質量%、好ましくは5~30質量%、更に好ましくは7~15質量%である。
かかる濃度が高すぎると、コーティング液の流動性が低下し、コーティングしにくくなる傾向があり、逆に低すぎると、乾燥に時間がかかり効率が低下する傾向がある。
コーティング液中のトリアセチン(B)の濃度は、通常1~20質量%、好ましくは1.5~10質量%、更に好ましくは2~7質量%である。
かかる濃度が高すぎると、錠剤表面でブリードアウトする傾向があり、逆に低すぎると、粘着性の改善が完全ではなくコーティング速度を上げることができない傾向がある。
The concentration of the PVA resin (A) in the coating liquid is usually 3 to 50% by weight, preferably 5 to 30% by weight, and more preferably 7 to 15% by weight.
If the concentration is too high, the fluidity of the coating liquid tends to decrease, making it difficult to coat, while if it is too low, drying tends to take a long time and efficiency decreases.
The concentration of triacetin (B) in the coating liquid is usually 1 to 20% by weight, preferably 1.5 to 10% by weight, and more preferably 2 to 7% by weight.
If the concentration is too high, there is a tendency for bleed-out on the tablet surface, whereas if it is too low, the improvement in adhesion is not complete and there is a tendency that the coating speed cannot be increased.
本発明のフィルムコーティング組成物は、必要に応じて、通常製剤学的に認められる公知の添加剤を含んでいてもよい。このような公知の添加剤としては、例えば、トリアセチン(B)以外の粘着防止剤(例えば、グリセリン、クエン酸トリエチル、ポリエチレングリコール)、ステアリン酸マグネシウム、ステアリン酸カルシウム、テアリン酸等の滑択剤、酸化チタン、炭酸カルシウム、二酸化ケイ素等の隠蔽剤、タルク、コロイダリシリカ等の無機化合物、界面活性剤、着色剤、顔料、甘味料、コーティング剤、消泡剤等が挙げられる。これらを添加する場合の含有量は、本発明の効果を妨げない限り、特に限定されないが、PVA系樹脂(A)に対して、好ましくは200質量%以下、更に好ましくは100質量%以下である。 The film coating composition of the present invention may contain known additives that are generally accepted pharmaceutically, if necessary. Such known additives include, for example, anti-blocking agents other than triacetin (B) (e.g., glycerin, triethyl citrate, polyethylene glycol), lubricants such as magnesium stearate, calcium stearate, and stearic acid, and oxidized Examples include masking agents such as titanium, calcium carbonate, and silicon dioxide, inorganic compounds such as talc and colloidal silica, surfactants, colorants, pigments, sweeteners, coating agents, and antifoaming agents. The content when adding these is not particularly limited as long as it does not impede the effects of the present invention, but it is preferably 200% by mass or less, more preferably 100% by mass or less based on the PVA resin (A). .
次に、本発明の固形製剤について説明する。
本発明の固形製剤は、有効成分を少なくとも含有する芯部と、該芯部を被覆する被覆部を有し、該被覆部が前記フィルムコーティング組成物を少なくとも含む。前記有効成分は、経口投与可能なものであれば特に限定されるものではない。
Next, the solid preparation of the present invention will be explained.
The solid preparation of the present invention has a core portion containing at least an active ingredient, and a coating portion covering the core portion, and the coating portion includes at least the film coating composition. The active ingredient is not particularly limited as long as it can be orally administered.
前記芯部には、賦形剤、結合剤、崩壊剤、滑択剤(凝集防止剤)、流動化剤、着色剤、医薬化合物の溶解補助剤等、通常この分野で常用され得る種々の添加剤を配合してもよい。 The core contains various additives that are commonly used in this field, such as excipients, binders, disintegrants, lubricants (anti-agglomeration agents), fluidizing agents, coloring agents, and solubilizing agents for pharmaceutical compounds. Agents may also be added.
賦形剤としては、特に限定されないが、例えば、白糖、乳糖、マンニトール、グルコース等の糖類、でんぷん、結晶セルロース、リン酸カルシウム、硫酸カルシウム等が挙げられる。 Excipients include, but are not particularly limited to, saccharides such as white sugar, lactose, mannitol, and glucose, starch, crystalline cellulose, calcium phosphate, and calcium sulfate.
結合剤としては、特に限定されないが、例えば、ポリビニルアルコール、ポリアクリル酸、ポリメタクリル酸、ポリビニルピロリドン、グルコース、白糖、乳糖、麦芽糖、デキストリン、ソルビトール、マンニトール、ヒドロキシエチルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシプロピルセルロース、マクロゴール類(例えば、マクロゴール4000、マクロゴール6000、マクロゴール20000等)、アラビアゴム、ゼラチン、寒天、でんぷん(コーンスターチ等)等が挙げられる。 Examples of binders include, but are not limited to, polyvinyl alcohol, polyacrylic acid, polymethacrylic acid, polyvinylpyrrolidone, glucose, sucrose, lactose, maltose, dextrin, sorbitol, mannitol, hydroxyethylcellulose, hydroxypropylmethylcellulose, hydroxypropylcellulose. , macrogol (eg, macrogol 4000, macrogol 6000, macrogol 20000, etc.), gum arabic, gelatin, agar, starch (cornstarch, etc.), and the like.
崩壊剤としては、特に限定されないが、例えば、低置換度ヒドロキシプロピルセルロース、カルメロース又はその塩、クロスカルメロースナトリウム、カルボキシメチルスターチナトリウム、クロスポリビニルピロリドン、結晶セルロース及び結晶セルロース・カルメロースナトリウム等が挙げられる。 Disintegrants include, but are not particularly limited to, low-substituted hydroxypropyl cellulose, carmellose or its salts, croscarmellose sodium, carboxymethyl starch sodium, crospolyvinylpyrrolidone, crystalline cellulose, and crystalline cellulose/carmellose sodium. It will be done.
滑択剤としては、特に限定されないが、例えば、タルク、ステアリン酸マグネシウム、ステアリン酸カルシウム、コロイダルシリカ、ステアリン酸、ワックス類、硬化油、ポリエチレングリコール類、安息香酸ナトリウム等が挙げられる。 Examples of the lubricant include, but are not limited to, talc, magnesium stearate, calcium stearate, colloidal silica, stearic acid, waxes, hydrogenated oils, polyethylene glycols, sodium benzoate, and the like.
流動化剤としては、特に限定されないが、例えば、含水二酸化ケイ素、軽質無水ケイ酸、酸化チタン等が挙げられる。 Examples of the fluidizing agent include, but are not limited to, hydrous silicon dioxide, light anhydrous silicic acid, titanium oxide, and the like.
更に、医薬化合物の溶解補助剤としては、フマル酸、コハク酸、リンゴ酸、アジピン酸等の有機酸等が挙げられる。これら添加剤の含有量は、薬剤の種類等に応じて適宜決定することができる。 Furthermore, examples of solubilizing agents for pharmaceutical compounds include organic acids such as fumaric acid, succinic acid, malic acid, and adipic acid. The content of these additives can be determined as appropriate depending on the type of drug and the like.
前記被覆部は、本発明のフィルムコーティング組成物を少なくとも含むものであればよく、本発明のフィルムコーティング組成物のみを被覆部(被覆層)としてもよく、本発明のフィルムコーティング組成物からなる被覆層の下に、コーティング基剤を用いてアンダーコーティングを行っていてもよい。前記コーティング基剤としては、HPMC等の通常この分野で常用され得る種々のコーティング基剤を使用することができる。被覆部の形態は、限定されず、層状、フィルム状等であってもよい。 The coating portion may include at least the film coating composition of the present invention, the coating portion (coating layer) may contain only the film coating composition of the present invention, and the coating portion may be a coating made of the film coating composition of the present invention. An undercoating may be performed below the layer using a coating base. As the coating base, various coating bases that can be commonly used in this field, such as HPMC, can be used. The form of the covering portion is not limited, and may be layered, film-like, or the like.
本発明のフィルムコーティング組成物によりコーティングされて得られる固形製剤としては、錠剤、散剤、顆粒剤、細粒剤、丸剤、トローチ剤、カプセル剤等が挙げられるが、その中でも特に錠剤が好ましい。錠剤としては、糖衣錠、ゼラチン被包錠、フィルムコーティング錠(多層フィルムコーティング錠を含む)、腸溶性コーティング錠、有核錠(圧縮被包錠)等の形態を有するものであってもよく、フィルムコーティング錠(多層フィルムコーティング錠を含む)、腸溶性コーティング錠が好ましい。 Solid preparations obtained by coating with the film coating composition of the present invention include tablets, powders, granules, fine granules, pills, troches, capsules, etc. Among these, tablets are particularly preferred. The tablets may be in the form of sugar-coated tablets, gelatin-encapsulated tablets, film-coated tablets (including multilayer film-coated tablets), enteric-coated tablets, dry-coated tablets (compressed encapsulated tablets), etc. Coated tablets (including multilayer film coated tablets) and enteric coated tablets are preferred.
次に、固形製剤の製造方法について説明する。
本発明の固形製剤は、本発明のフィルムコーティング組成物を溶媒に溶解又は分散させたフィルムコーティング液を調製し、該フィルムコーティング液を芯部に塗布することで製造できる。
Next, a method for producing a solid preparation will be explained.
The solid preparation of the present invention can be produced by preparing a film coating liquid in which the film coating composition of the present invention is dissolved or dispersed in a solvent, and applying the film coating liquid to the core.
前記溶媒としては、特に限定されず、例えば、前述した水又はエタノール等の有機溶媒を用いることができ、これらは一種単独で使用してもよく、2種以上を混合して混合溶媒として使用することもできる。また、本発明のフィルムコーティング組成物を溶媒に溶解又は分散させる際の温度は、特に限定されないが、加熱していてもよく、5~70℃程度であってもよい。 The solvent is not particularly limited, and for example, the above-mentioned organic solvents such as water or ethanol may be used, and these may be used alone or two or more may be used as a mixed solvent. You can also do that. Further, the temperature at which the film coating composition of the present invention is dissolved or dispersed in a solvent is not particularly limited, but may be heated, and may be about 5 to 70°C.
前記塗布方法としては、例えば、上記のように調製した本発明のフィルムコーティング組成物溶液を、有効成分を含有する芯部に、従来公知のコーティング装置を用いて噴霧等により塗布する方法が挙げられる。 Examples of the coating method include a method of coating the film coating composition solution of the present invention prepared as described above onto the core containing the active ingredient by spraying or the like using a conventionally known coating device. .
また、本発明の固形製剤が多層フィルムコーティング錠である場合、本発明のフィルムコーティング組成物からなるフィルム層の下に、前記塗布方法の塗布を行う前に、HPMC等の通常この分野で常用され得る種々のコーティング基剤を用いてアンダーコーティングを行う工程を加えて、複数のフィルムを形成させる方法も挙げられる。 In addition, when the solid preparation of the present invention is a multilayer film-coated tablet, before applying the above-mentioned coating method under the film layer consisting of the film-coating composition of the present invention, a film coated with HPMC or the like commonly used in this field may be used. There is also a method in which a plurality of films are formed by adding a step of undercoating using various coating bases obtained.
前記コーティング装置としては、特に限定されず、従来公知の手段を用いることができる。コーティング方法として、一般的に行われているのはスプレーコーティングであるが、その場合は、パンコーティング装置、ドラムタイプコーティング装置、流動層コーティング装置、撹拌流動コーティング装置を用いて行えばよく、これらの装置に付帯するスプレー装置には、エアースプレー、エアレススプレー、3流体スプレー等のいずれをも用いることができる。 The coating device is not particularly limited, and conventionally known means can be used. Spray coating is commonly used as a coating method, but in that case, it can be carried out using pan coating equipment, drum type coating equipment, fluidized bed coating equipment, and stirring fluidized coating equipment. As the spray device attached to the device, any of air spray, airless spray, three-fluid spray, etc. can be used.
芯部(素錠)の表面にコーティングされるフィルムコーティング組成物の被覆量は、固形製剤の種類、形、大きさ、表面状態、更に固形製剤中に含まれる有効成分及び添加剤の性質等によって異なるが、例えば、芯部(素錠)に対して、好ましくは1~10質量%であり、更に好ましくは1~7質量%であり、特に好ましくは2~6質量%である。被覆量が少なすぎると、完全な皮膜が得られず、逆に多すぎるとコーティングに要する時間が必要となる場合がある。 The amount of film coating composition coated on the surface of the core (uncoated tablet) depends on the type, shape, size, surface condition of the solid preparation, and the properties of the active ingredients and additives contained in the solid preparation. Although different, for example, it is preferably 1 to 10% by mass, more preferably 1 to 7% by mass, particularly preferably 2 to 6% by mass, based on the core (uncoated tablet). If the coating amount is too small, a complete film may not be obtained, and if the coating amount is too large, the coating may require more time.
また、本発明の錠剤コーティング組成物を用いて固形製剤を製造することで表面が滑らかな固形製剤を提供できる。表面粗さ(Ra)の値が2.0μm以下であることが好ましい。なお、表面粗さ(Ra)とはJIS B0601-1994に定義されている粗さパラメーターであり、レーザー顕微鏡(VK-9510、キーエンス社製)を用いて、50倍率の対物レンズを用いて測定できる。 Further, by manufacturing a solid preparation using the tablet coating composition of the present invention, a solid preparation with a smooth surface can be provided. It is preferable that the value of surface roughness (Ra) is 2.0 μm or less. Note that surface roughness (Ra) is a roughness parameter defined in JIS B0601-1994, and can be measured using a laser microscope (VK-9510, manufactured by Keyence Corporation) with a 50x objective lens. .
次に、実施例を挙げて本発明をさらに具体的に説明するが、本発明はこれらの実施例により何ら限定されるものではない。また、単に「部」「%」とあるのは、質量基準である。 Next, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited to these Examples in any way. Furthermore, "parts" and "%" are based on mass.
実施例1
PVA系樹脂(A)(未変性、ケン化度88モル%、4%水溶液粘度3mPa・s)100部、タルクを38部、二酸化チタンを38部、トリアセチン(B)を33部を含有するコーティング組成物を得て、水625部を配合し、85℃に昇温させ溶解し、コーティング組成物の水溶液を得た。
Example 1
Coating containing 100 parts of PVA resin (A) (unmodified, degree of saponification 88 mol%, viscosity of 4% aqueous solution 3 mPa・s), 38 parts of talc, 38 parts of titanium dioxide, and 33 parts of triacetin (B) A composition was obtained, 625 parts of water was blended, and the mixture was heated to 85° C. to dissolve, thereby obtaining an aqueous solution of a coating composition.
連続通気式コーティング装置(フロイント産業(株)製、ハイコーターラボ)に、被覆対象となる芯部は、素錠(φ=9mm)を900部、シリカ錠(φ=11mm)を100部、計1000部となるように仕込み、コーティング組成物の水溶液を30部スプレーし、素錠及びシリカ錠にコーティングした。 The cores to be coated were 900 parts of plain tablets (φ = 9 mm) and 100 parts of silica tablets (φ = 11 mm) in a continuous ventilation coating device (manufactured by Freund Sangyo Co., Ltd., Hi-Coater Lab). A total of 1000 parts was prepared, and 30 parts of an aqueous solution of the coating composition was sprayed to coat plain tablets and silica tablets.
コーティング条件は、以下の通りであった。
給気温度 :70℃
排気温度 :40~55℃
給気空気量 :1.2m3/min
スプレーガン :1個
アトマイズドエア量:80NL/min
アトマイズド空気圧:0.3MPa
スプレー速度 :6~8g/min
The coating conditions were as follows.
Supply air temperature: 70℃
Exhaust temperature: 40-55℃
Supply air amount: 1.2m3/min
Spray gun: 1 piece Atomized air amount: 80NL/min
Atomized air pressure: 0.3MPa
Spray speed: 6-8g/min
〔スティッキングの有無〕
コーティング中の素錠を目視で観察し、以下の基準でスティッキングの有無を評価した。結果を表1に示す。
有:素錠同士が接着しているものがあった
無:素錠同士が接着しているものはなかった
[Presence or absence of sticking]
The coated uncoated tablets were visually observed and the presence or absence of sticking was evaluated based on the following criteria. The results are shown in Table 1.
Yes: There were cases where plain tablets were glued together.No: There were no cases where plain tablets were glued together.
〔吸湿性〕
上記で得られたコーティングされたシリカ錠を10錠1セットとし、60℃で12時間以上乾燥させ、その質量を初期質量とし、25℃75%RHの恒温恒湿器に静置し、8時間後の吸湿率を質量増加より求めた。結果を表1に示す。
[Hygroscopicity]
A set of 10 coated silica tablets obtained above was dried at 60°C for 12 hours or more, its mass was taken as the initial mass, and it was left standing in a constant temperature and humidity chamber at 25°C and 75% RH for 8 hours. The subsequent moisture absorption rate was determined from the mass increase. The results are shown in Table 1.
実施例2
実施例1において、PVA系樹脂(A)(未変性、ケン化度88モル%、4%水溶液粘度5mPa・s)100部、タルクを25部、二酸化チタンを17部、トリアセチン(B)を25部、水944部の組成とした以外は、実施例1と同様にコーティング組成物の水溶液を作製し、同様に評価した。
Example 2
In Example 1, 100 parts of PVA resin (A) (unmodified, degree of saponification 88 mol%, viscosity of 4% aqueous solution 5 mPa s), 25 parts of talc, 17 parts of titanium dioxide, 25 parts of triacetin (B) An aqueous solution of the coating composition was prepared in the same manner as in Example 1, except that the composition was 944 parts and 944 parts of water, and evaluated in the same manner.
比較例1
実施例1において、トリアセチン(B)を重量平均重合度4000のポリエチレングリコール(PEG4000)とした以外は、実施例1と同様にコーティング水溶液を作製し、同様に評価した。
Comparative example 1
In Example 1, a coating aqueous solution was prepared in the same manner as in Example 1, except that triacetin (B) was changed to polyethylene glycol (PEG4000) with a weight average degree of polymerization of 4000, and evaluated in the same manner.
比較例2
実施例2において、トリアセチン(B)をプロピレングリコールとした以外は、実施例2と同様にコーティング水溶液を作製し、同様に評価した。
Comparative example 2
In Example 2, a coating aqueous solution was prepared in the same manner as in Example 2, except that propylene glycol was used as triacetin (B), and evaluated in the same manner.
比較例3
実施例2において、トリアセチン(B)をグリセリンとした以外は、実施例2と同様にコーティング水溶液を作製し、同様に評価した。
Comparative example 3
In Example 2, a coating aqueous solution was prepared in the same manner as in Example 2, except that glycerin was used instead of triacetin (B), and evaluated in the same manner.
比較例4
PVA系樹脂(A)(未変性、ケン化度88モル%、4%水溶液粘度5mPa・s)100部、タルクを50部、トリアセチン(B)を17部を含有するコーティング組成物を得て、水501部を配合し、85℃に昇温させ溶解し、コーティング組成物の水溶液を得、実施例1と同様に評価した。
Comparative example 4
Obtain a coating composition containing 100 parts of PVA resin (A) (unmodified, degree of saponification 88 mol%, 4% aqueous solution viscosity 5 mPa s), 50 parts of talc, and 17 parts of triacetin (B), 501 parts of water was blended and the mixture was heated to 85° C. to dissolve it to obtain an aqueous solution of the coating composition, which was evaluated in the same manner as in Example 1.
比較例5
実施例1において、PVA系樹脂(A)を未変性、ケン化度88モル%、4%水溶液粘度5mPa・sのものに変え、トリアセチン(B)をジアセチンとした以外は、実施例1と同様にコーティング水溶液を作製し、同様に評価した。
Comparative example 5
In Example 1, the same as in Example 1 except that the PVA resin (A) was changed to an unmodified one with a degree of saponification of 88 mol% and a 4% aqueous solution viscosity of 5 mPa・s, and triacetin (B) was replaced with diacetin. A coating aqueous solution was prepared and evaluated in the same manner.
本発明のフィルムコーティング組成物を用いた実施例1及び2は、スティッキングがなく、吸湿性も低かった。
一方、本発明のコーティグを用いなかった比較例1~5はスティッキング、もしくは吸湿を引き起こした。
Examples 1 and 2 using the film coating composition of the present invention had no sticking and low hygroscopicity.
On the other hand, Comparative Examples 1 to 5 in which the coating of the present invention was not used caused sticking or moisture absorption.
本発明のフィルムコーティング組成物は、医薬品、健康食品、食品等の錠剤の被膜として有用であり、特に、水分活性の高い成分を含む錠剤の被膜、およびスティッキングが懸念されるコーティング工程において有用である。 The film coating composition of the present invention is useful as a coating for tablets of pharmaceuticals, health foods, foods, etc., and is particularly useful as a coating for tablets containing components with high water activity, and in coating processes where sticking is a concern. .
Claims (5)
性ポリビニルアルコール系樹脂(A)とトリアセチン(B)を含有するフィルムコーティ
ング組成物を含むコーティング液において、
前記ポリビニルアルコール系樹脂(A)のケン化度70~98モル%であり、
トリアセチン(B)の含有量が、ポリビニルアルコール系樹脂(A)100質量部に対
して20~40質量部であり、
コーティング液中の固形分に対するトリアセチン(B)含有量が15質量%以上であり
、糖類を含まないことを特徴とするフィルムコーティング組成物を含むコーティング液。 In a coating liquid containing a film coating composition containing an unmodified polyvinyl alcohol resin (A) consisting only of vinyl alcohol structural units and unsaponified vinyl ester structural units and triacetin (B),
The degree of saponification of the polyvinyl alcohol resin (A) is 70 to 98 mol%,
The content of triacetin (B) is 20 to 40 parts by mass based on 100 parts by mass of polyvinyl alcohol resin (A),
The triacetin (B) content based on the solid content in the coating liquid is 15% by mass or more.
, a coating liquid containing a film coating composition characterized in that it does not contain sugars.
する請求項1記載のフィルムコーティング組成物を含むコーティング液。 A coating liquid containing the film coating composition according to claim 1, wherein the degree of saponification of the polyvinyl alcohol resin (A) is 80 to 95 mol%.
ング組成物を含むコーティング液。 A coating liquid comprising the film coating composition according to claim 1 or 2, which is a film coating composition for solid preparations.
請求項1~3のいずれか1項に記載のフィルムコーティング組成物を含むコーティング液
から形成される固形製剤。 A coating liquid comprising a core portion containing at least an active ingredient and a coating portion covering the core portion, the coating portion containing the film coating composition according to any one of claims 1 to 3.
A solid preparation formed from .
コーティング組成物を含むコーティング液を塗布する工程を少なくとも含む固形製剤の製
造方法。 A method for producing a solid preparation, which comprises at least the step of applying a coating liquid containing the film coating composition according to any one of claims 1 to 3 to a core portion containing at least an active ingredient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018183810 | 2018-09-28 | ||
JP2018183810 | 2018-09-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020055794A JP2020055794A (en) | 2020-04-09 |
JP7363189B2 true JP7363189B2 (en) | 2023-10-18 |
Family
ID=70106421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019151722A Active JP7363189B2 (en) | 2018-09-28 | 2019-08-22 | Film coating composition, solid preparation, and method for producing solid preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7363189B2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006111980A2 (en) | 2005-04-20 | 2006-10-26 | Ideal Cures Pvt. Ltd. | Pva based film coating and film coating compositions |
WO2006111981A3 (en) | 2005-04-20 | 2007-02-01 | Ideal Cures Pvt Ltd | Film coating compositions and methods providing moisture barrier |
WO2016108250A1 (en) | 2015-01-01 | 2016-07-07 | Ideal Cures Pvt. Ltd. | Novel film coating composition |
CN106139157A (en) | 2016-08-23 | 2016-11-23 | 杨育平 | A kind of reinforced membranes coating pre-mixing agent and preparation method |
CN106214658A (en) | 2016-08-29 | 2016-12-14 | 北京英茂药业有限公司 | A kind of compound coating pre-mixing agent and preparation method thereof |
-
2019
- 2019-08-22 JP JP2019151722A patent/JP7363189B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006111980A2 (en) | 2005-04-20 | 2006-10-26 | Ideal Cures Pvt. Ltd. | Pva based film coating and film coating compositions |
WO2006111981A3 (en) | 2005-04-20 | 2007-02-01 | Ideal Cures Pvt Ltd | Film coating compositions and methods providing moisture barrier |
WO2016108250A1 (en) | 2015-01-01 | 2016-07-07 | Ideal Cures Pvt. Ltd. | Novel film coating composition |
CN106139157A (en) | 2016-08-23 | 2016-11-23 | 杨育平 | A kind of reinforced membranes coating pre-mixing agent and preparation method |
CN106214658A (en) | 2016-08-29 | 2016-12-14 | 北京英茂药业有限公司 | A kind of compound coating pre-mixing agent and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
機能材料,1996年,16(11),pp.38-44 |
Also Published As
Publication number | Publication date |
---|---|
JP2020055794A (en) | 2020-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101783945B1 (en) | Enhanced moisture barrier immediate release film coating systems and substrates coated therewith | |
EP1476139B1 (en) | Controlled release dosage forms | |
KR102490265B1 (en) | Hypromellose acetate succinate and method for producing the same | |
EP2474324A1 (en) | Coating composition | |
US20220378709A1 (en) | Novel film coating composition | |
KR20120033305A (en) | Film coatings containing fine particle size detackifiers and substrates coated therewith | |
JP7363189B2 (en) | Film coating composition, solid preparation, and method for producing solid preparation | |
RU2593771C2 (en) | Enteric-coated tablet | |
MX2011002790A (en) | Smooth, high solids tablet coating composition. | |
US8741051B2 (en) | Coating composition comprising polydextrose, process for preparing same and use of coating ingestible solid forms | |
JP7119913B2 (en) | Film coating composition, solid formulation and method for producing solid formulation | |
JP6403615B2 (en) | Film coating composition, oral solid preparation and method for producing the same | |
JP7379263B2 (en) | binder | |
JP6396220B2 (en) | Film coating liquid, oral solid preparation and method for producing the same | |
US20210371691A1 (en) | Smooth high solids film coating composition comprising water soluble cellulose ether, process for preparing the same and method of use thereof | |
JPWO2020100932A1 (en) | Binder | |
EP3011973B1 (en) | Coating agent containing hydroxyalkyl cellulose | |
JP7189689B2 (en) | Coating composition and oral solid dosage form and manufacturing method thereof | |
EP2705839B1 (en) | Pharmaceutical composition comprising lacidipine and process of preparation | |
KR102011512B1 (en) | Film coating composition and oral solid preparation | |
JP2016196438A (en) | Film coating composition and oral solid preparation and method for producing the same | |
US20240000712A1 (en) | Composition for sustained-release solid dosage form, sustained-release tablet using the same, and manufacturing method thereof | |
WO2023027056A1 (en) | Composition for medicinal tablet, medicinal tablet obtained using same, and production method therefor | |
JP2024009644A (en) | Intraoral adhesive agent and method for producing the same | |
KR20200143724A (en) | Acidified coating and coated degradation resistant substrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220218 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20221118 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221122 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230112 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230130 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230425 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230607 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230822 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230905 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230918 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 7363189 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |